191 related articles for article (PubMed ID: 7705549)
1. Colonic mucosal interleukin 1 receptor antagonist in inflammatory bowel disease.
Nishiyama T; Mitsuyama K; Toyonaga A; Sasaki E; Tanikawa K
Digestion; 1994; 55(6):368-73. PubMed ID: 7705549
[TBL] [Abstract][Full Text] [Related]
2. Imbalance of the interleukin 1 system in colonic mucosa--association with intestinal inflammation and interleukin 1 receptor antagonist [corrected] genotype 2.
Andus T; Daig R; Vogl D; Aschenbrenner E; Lock G; Hollerbach S; Köllinger M; Schölmerich J; Gross V
Gut; 1997 Nov; 41(5):651-7. PubMed ID: 9414973
[TBL] [Abstract][Full Text] [Related]
3. Relationship of interleukin-1 receptor antagonist to mucosal inflammation in inflammatory bowel disease.
Hyams JS; Fitzgerald JE; Wyzga N; Muller R; Treem WR; Justinich CJ; Kreutzer DL
J Pediatr Gastroenterol Nutr; 1995 Nov; 21(4):419-25. PubMed ID: 8583293
[TBL] [Abstract][Full Text] [Related]
4. Mucosal imbalance of IL-1 and IL-1 receptor antagonist in inflammatory bowel disease. A novel mechanism of chronic intestinal inflammation.
Casini-Raggi V; Kam L; Chong YJ; Fiocchi C; Pizarro TT; Cominelli F
J Immunol; 1995 Mar; 154(5):2434-40. PubMed ID: 7868909
[TBL] [Abstract][Full Text] [Related]
5. Colonic explant production of IL-1and its receptor antagonist is imbalanced in inflammatory bowel disease (IBD).
Dionne S; D'Agata ID; Hiscott J; Vanounou T; Seidman EG
Clin Exp Immunol; 1998 Jun; 112(3):435-42. PubMed ID: 9649212
[TBL] [Abstract][Full Text] [Related]
6. Expression of interleukin 1 beta and interleukin 1 beta converting enzyme by intestinal macrophages in health and inflammatory bowel disease.
McAlindon ME; Hawkey CJ; Mahida YR
Gut; 1998 Feb; 42(2):214-9. PubMed ID: 9536946
[TBL] [Abstract][Full Text] [Related]
7. Influence of interleukin-10 on the interleukin-1 receptor antagonist/interleukin-1 beta ratio in the colonic mucosa of ulcerative colitis.
Ishizuka K; Sugimura K; Homma T; Matsuzawa J; Mochizuki T; Kobayashi M; Suzuki K; Otsuka K; Tashiro K; Yamaguchi O; Asakura H
Digestion; 2001; 63 Suppl 1():22-7. PubMed ID: 11173905
[TBL] [Abstract][Full Text] [Related]
8. Lamina propria and circulating interleukin-8 in newly and previously diagnosed pediatric inflammatory bowel disease patients.
Reddy KP; Markowitz JE; Ruchelli ED; Baldassano RN; Brown KA
Dig Dis Sci; 2007 Feb; 52(2):365-72. PubMed ID: 17219072
[TBL] [Abstract][Full Text] [Related]
9. Imbalance between interleukin-1 agonists and antagonists: relationship to severity of inflammatory bowel disease.
Ludwiczek O; Vannier E; Borggraefe I; Kaser A; Siegmund B; Dinarello CA; Tilg H
Clin Exp Immunol; 2004 Nov; 138(2):323-9. PubMed ID: 15498044
[TBL] [Abstract][Full Text] [Related]
10. Interleukin-1 receptor antagonist in differential diagnosis of inflammatory bowel diseases.
Propst A; Propst T; Herold M; Vogel W; Judmaier G
Eur J Gastroenterol Hepatol; 1995 Nov; 7(11):1031-6. PubMed ID: 8680901
[TBL] [Abstract][Full Text] [Related]
11. Impaired response of activated mononuclear phagocytes to interleukin 4 in inflammatory bowel disease.
Schreiber S; Heinig T; Panzer U; Reinking R; Bouchard A; Stahl PD; Raedler A
Gastroenterology; 1995 Jan; 108(1):21-33. PubMed ID: 7806044
[TBL] [Abstract][Full Text] [Related]
12. Immunoregulatory role of interleukin 10 in patients with inflammatory bowel disease.
Schreiber S; Heinig T; Thiele HG; Raedler A
Gastroenterology; 1995 May; 108(5):1434-44. PubMed ID: 7729636
[TBL] [Abstract][Full Text] [Related]
13. Mucosal inflammatory cytokine production by intestinal biopsies in patients with ulcerative colitis and Crohn's disease.
Reimund JM; Wittersheim C; Dumont S; Muller CD; Baumann R; Poindron P; Duclos B
J Clin Immunol; 1996 May; 16(3):144-50. PubMed ID: 8734357
[TBL] [Abstract][Full Text] [Related]
14. Increased circulating levels of interleukin-1 receptor antagonist in patients with inflammatory bowel disease.
Kuboyama S
Kurume Med J; 1998; 45(1):33-7. PubMed ID: 9658748
[TBL] [Abstract][Full Text] [Related]
15. Modulation of cytokine release from colonic explants by bacterial antigens in inflammatory bowel disease.
Dionne S; Laberge S; Deslandres C; Seidman EG
Clin Exp Immunol; 2003 Jul; 133(1):108-14. PubMed ID: 12823284
[TBL] [Abstract][Full Text] [Related]
16. Epithelial expression of interleukin-37b in inflammatory bowel disease.
Imaeda H; Takahashi K; Fujimoto T; Kasumi E; Ban H; Bamba S; Sonoda H; Shimizu T; Fujiyama Y; Andoh A
Clin Exp Immunol; 2013 Jun; 172(3):410-6. PubMed ID: 23600829
[TBL] [Abstract][Full Text] [Related]
17. Five genetic markers in the interleukin 1 family in relation to inflammatory bowel disease.
Stokkers PC; van Aken BE; Basoski N; Reitsma PH; Tytgat GN; van Deventer SJ
Gut; 1998 Jul; 43(1):33-9. PubMed ID: 9771403
[TBL] [Abstract][Full Text] [Related]
18. Impact of selective leukocytapheresis on mucosal inflammation and ulcerative colitis: cytokine profiles and endoscopic findings.
Yamamoto T; Saniabadi AR; Umegae S; Matsumoto K
Inflamm Bowel Dis; 2006 Aug; 12(8):719-26. PubMed ID: 16917227
[TBL] [Abstract][Full Text] [Related]
19. Gut lavage IgG and interleukin 1 receptor antagonist:interleukin 1 beta ratio as markers of intestinal inflammation in children with inflammatory bowel disease.
Troncone R; Caputo N; Campanozzi A; Cucciardi M; Esposito V; Russo R; De Vizia B; Greco L; Cucchiara S
Gut; 1997 Jul; 41(1):60-5. PubMed ID: 9274473
[TBL] [Abstract][Full Text] [Related]
20. Respiratory burst of intestinal macrophages in inflammatory bowel disease is mainly caused by CD14+L1+ monocyte derived cells.
Rugtveit J; Haraldsen G; Høgåsen AK; Bakka A; Brandtzaeg P; Scott H
Gut; 1995 Sep; 37(3):367-73. PubMed ID: 7590432
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]